Freenome Holdings, Inc., a company specializing in early cancer detection through blood-based screening tests, and Perceptive Capital Solutions Corp. have entered into a definitive agreement to combine their businesses. Upon completion of the transaction, the newly formed company will be named Freenome, Inc. and is expected to be listed on Nasdaq under the ticker symbol FRNM. The deal includes a $240 million private investment in public equity led by Perceptive Advisors and RA Capital, alongside approximately $90 million currently held in trust by Perceptive Capital Solutions Corp., assuming no shareholder redemptions. The business combination is expected to close in the first half of 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perceptive Capital Solutions Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF40252) on December 05, 2025, and is solely responsible for the information contained therein.